Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2006 4
2008 1
2010 7
2011 2
2013 4
2014 4
2015 8
2016 5
2017 6
2018 9
2019 9
2020 3
2021 5
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.
Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M, Yan Y, Lo S, Carlino MS, Guminski A, Saw RPM, Pang A, McGuire HM, Palendira U, Thompson JF, Rizos H, Silva IPD, Batten M, Scolyer RA, Long GV, Wilmott JS. Gide TN, et al. Among authors: holst j. Cancer Cell. 2019 Feb 11;35(2):238-255.e6. doi: 10.1016/j.ccell.2019.01.003. Cancer Cell. 2019. PMID: 30753825 Free article.
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
Sharbeen G, McCarroll JA, Akerman A, Kopecky C, Youkhana J, Kokkinos J, Holst J, Boyer C, Erkan M, Goldstein D, Timpson P, Cox TR, Pereira BA, Chitty JL, Fey SK, Najumudeen AK, Campbell AD, Sansom OJ, Ignacio RMC, Naim S, Liu J, Russia N, Lee J, Chou A, Johns A, Gill AJ, Gonzales-Aloy E, Gebski V, Guan YF, Pajic M, Turner N, Apte MV, Davis TP, Morton JP, Haghighi KS, Kasparian J, McLean BJ, Setargew YF, Phillips PA; Australian Pancreatic Cancer Genome Initiative. Sharbeen G, et al. Among authors: holst j. Cancer Res. 2021 Jul 1;81(13):3461-3479. doi: 10.1158/0008-5472.CAN-20-2496. Epub 2021 May 12. Cancer Res. 2021. PMID: 33980655
ASCT2: a potential cancer drug target.
Wahi K, Holst J. Wahi K, et al. Among authors: holst j. Expert Opin Ther Targets. 2019 Jul;23(7):555-558. doi: 10.1080/14728222.2019.1627328. Epub 2019 Jun 4. Expert Opin Ther Targets. 2019. PMID: 31159623 No abstract available.
p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS, Xie C, Yao M, Holst J, Bensoussan A, De Souza P, Li Z, Dong Q. Hnit SS, et al. Among authors: holst j. Int J Biochem Cell Biol. 2015 Nov;68:9-14. doi: 10.1016/j.biocel.2015.08.005. Epub 2015 Aug 14. Int J Biochem Cell Biol. 2015. PMID: 26279144 Review.
ROS-mediated anticancer effects of EGFR-targeted nanoceria.
Johnson KK, Koshy P, Kopecky C, Devadason M, Biazik J, Zheng X, Jiang Y, Wang X, Liu Y, Holst J, Yang JL, Kilian KA, Sorrell CC. Johnson KK, et al. Among authors: holst j. J Biomed Mater Res A. 2024 May;112(5):754-769. doi: 10.1002/jbm.a.37656. Epub 2023 Dec 12. J Biomed Mater Res A. 2024. PMID: 38084898
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.
Nassar ZD, Mah CY, Dehairs J, Burvenich IJ, Irani S, Centenera MM, Helm M, Shrestha RK, Moldovan M, Don AS, Holst J, Scott AM, Horvath LG, Lynn DJ, Selth LA, Hoy AJ, Swinnen JV, Butler LM. Nassar ZD, et al. Among authors: holst j. Elife. 2020 Jul 20;9:e54166. doi: 10.7554/eLife.54166. Elife. 2020. PMID: 32686647 Free PMC article.
Identifying microRNA determinants of human myelopoiesis.
Rajasekhar M, Schmitz U, Flamant S, Wong JJ, Bailey CG, Ritchie W, Holst J, Rasko JEJ. Rajasekhar M, et al. Among authors: holst j. Sci Rep. 2018 May 8;8(1):7264. doi: 10.1038/s41598-018-24203-7. Sci Rep. 2018. PMID: 29739970 Free PMC article.
75 results